LTGO Earnings Date: Nov 19, 2026 (Estimated) — Latigo Biotherapeutics Inc.
NASDAQ
Updated
When is LTGO's next earnings date?
Latigo Biotherapeutics Inc. (LTGO) is expected to report Q3 2026 earnings on Thursday, November 19, 2026 at 1:40 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.67.
How did LTGO do in its last earnings report?
In its most recent report on Sep 3, 2026 (Q2 2026), Latigo Biotherapeutics Inc. posted EPS of -$27.59 versus the -$0.62 estimate, a miss of 5897.8%. Revenue was $0. The stock's 1-day post-earnings move was +2.5%.
How much does LTGO stock move after earnings?
LTGO beat EPS estimates in 0 of its last 1 reported quarter.
About Latigo Biotherapeutics Inc.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | Q2 2026 | -0.62 | -27.59 | -5897.83% | $0 | ❌ Miss | +2.49% | -1.47% | -26.02% |
Showing last 1 quarters.